SLNO Soleno Therapeutics, Inc.

HealthcareBiotechnology

$52.95

▲ 0.02%

39

QScore Signal

Hold

Confidence: MEDIUM

Long-Term

38

Short-Term

40

Value

35

P/E28.72

47

P/B5.56

44

P/S9.68

25

EV/EBITDA25.90

24

Growth

45

Revenue Growth0.0%

28

EPS Growth109.4%

51

FCF Growth167.4%

63

Momentum

56

12-Month Return-28.2%

26

3-Month Return33.8%

100

1-Month Return0.7%

54

RSI (14)63.93

76

50/200 MABearish

30

Profitability

61

ROE22.9%

56

ROA15.8%

80

Gross Margin65.9%

56

Operating Margin30.6%

64

Net Margin33.7%

78

FCF Yield3.8%

38

Risk

5

Beta-2.22

10

60-Day Volatility76.2%

0

Generated 5/7/2026, 11:33:27 PM · How is this calculated?

QScore Analysis